Copeland Capital Management LLC Purchases New Position in CVS Health Co. (NYSE:CVS)

Copeland Capital Management LLC acquired a new stake in CVS Health Co. (NYSE:CVSFree Report) in the fourth quarter, Holdings Channel.com reports. The firm acquired 2,325 shares of the pharmacy operator’s stock, valued at approximately $104,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health during the third quarter valued at about $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the period. Livelsberger Financial Advisory bought a new position in CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter valued at $31,000. Finally, Reston Wealth Management LLC bought a new position in shares of CVS Health in the third quarter worth $32,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CVS shares. TD Cowen boosted their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Truist Financial cut their price target on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.

View Our Latest Stock Report on CVS Health

CVS Health Trading Down 0.5 %

Shares of CVS opened at $56.53 on Monday. The firm has a fifty day simple moving average of $51.24 and a two-hundred day simple moving average of $56.16. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The stock has a market capitalization of $71.13 billion, a P/E ratio of 14.35, a PEG ratio of 0.62 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVSGet Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period last year, the firm earned $2.21 earnings per share. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. On average, research analysts anticipate that CVS Health Co. will post 5.18 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.71%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.